Background and rationale
Every country, regardless of its economic level, faces challenges in meeting the needs of its health systems to satisfy its populations, regardless of its level of resources (Pichon-Riviere et al. 2023). The situation becomes increasingly difficult as nations strive to ensure access to health care for all, whether in terms of who is covered, what type of treatment is given, or how much it costs the population, which poses the difficult task of making trade-offs between costs and benefits (which requires efficiency), as well as between equity and other social values. Health systems are primarily designed to improve health and efficiency, that is, the amount of health achieved relative to the amount of resources spent. The use of cost-effectiveness estimates for policymaking faces a number of barriers in the majority of low- and middle-income countries that require careful attention (Shillcutt et al. 2009). These include the lack of information on the costs and effects of interventions, the very small number of cost-effectiveness analyses conducted, the lack of evidence on the costs and effects of packages of measures, and the difficulty of generalizing or comparing studies from specific settings using different methodologies and outcome measures. Setting priorities in public health and health policy is important but complex (Stratil et al. 2020). Systematic assessment of evidence and other factors requires careful evaluation of many, often conflicting, normative and technical requirements. The choice of which factors to use as standards has a significant influence on the outcome of the decision-making process. Cost and effectiveness have been the primary considerations in many decision-making processes that directly impact health. This contrasts with the complexity of real-world decision-making, where normative and practical factors can play a major role in guiding choices. Establishing a systematic process to inform priority setting and decision-making can help optimize resources and minimize opportunity costs associated with lower-impact investments.
